Search Results - "Akakura, Koichiro"

Editorial Comment to External beam radiotherapy and radical prostatectomy are associated with better survival in Asian prostate cancer patients by Akakura, Koichiro

Get full text

Editorial Comment to Impact of alternative antiandrogen therapy for Japanese prostate cancer patients in the era of new hormonal therapy by Akakura, Koichiro

Get full text

Pretreatment PSA levels affects the completion rate of Ra-223 treatment by Utsumi, Nobuko, Kurosaki, Hiromasa, Miura, Kosei, Kitoh, Hiroki, Akakura, Koichiro

“…The aim of this study was to review our initial experience of using radium 223 (Ra-223) for metastatic castration-resistant prostate cancer (CRPC) and to…”
Get full text

Editorial Comment from Dr Akakura to Early radiotherapy after radical prostatectomy improves cancer-specific survival only in patients with highly aggressive prostate cancer: Validation of recently released criteria by Akakura, Koichiro

Get full text

Author Correction: Pretreatment PSA levels affects the completion rate of Ra-223 treatment by Utsumi, Nobuko, Kurosaki, Hiromasa, Miura, Kosei, Kitoh, Hiroki, Akakura, Koichiro

Get full text

Carbon‐ion radiotherapy for urological cancers by Ishikawa, Hitoshi, Hiroshima, Yuichi, Kanematsu, Nobuyuki, Inaniwa, Taku, Shirai, Toshiyuki, Imai, Reiko, Suzuki, Hiroyoshi, Akakura, Koichiro, Wakatsuki, Masaru, Ichikawa, Tomohiko, Tsuji, Hiroshi

“…Carbon‐ions are charged particles with a high linear energy transfer, and therefore, they make a better dose distribution with greater biological effects on…”
Get full text

Patients’ poor performance status is an independent risk factor for urosepsis induced by kidney and ureteral stones by Kino, Mika, Hayashi, Takumi, Hino, Daichi, Nakada, Takako, Kitoh, Hiroki, Akakura, Koichiro

“…This study was aimed to identify the risk factors for urosepsis caused by kidney and ureteral stones. One hundred and nine patients who had kidney or ureteral…”
Get full text

Personalizing Androgen Suppression for Prostate Cancer Using Mathematical Modeling by Hirata, Yoshito, Morino, Kai, Akakura, Koichiro, Higano, Celestia S., Aihara, Kazuyuki

“…Using a dataset of 150 patients treated with intermittent androgen suppression (IAS) through a fixed treatment schedule, we retrospectively designed a…”
Get full text

Carbon-ion radiation therapy for prostate cancer by Ishikawa, Hitoshi, Tsuji, Hiroshi, Kamada, Tadashi, Akakura, Koichiro, Suzuki, Hiroyoshi, Shimazaki, Jun, Tsujii, Hirohiko

“…In 1994, carbon‐ion radiotherapy was started at the National Institute of Radiological Sciences using the Heavy‐Ion Medical Accelerator in Chiba. Between June…”
Get full text

Chronological changes in the epidemiological characteristics of upper urinary tract urolithiasis in Japan by Sakamoto, Shinichi, Miyazawa, Katsuhito, Yasui, Takahiro, Iguchi, Taro, Fujita, Misuzu, Nishimatsu, Hiroaki, Masaki, Takuro, Hasegawa, Toru, Hibi, Hatsuki, Arakawa, Takashi, Ando, Ryosuke, Kato, Yoshinari, Ishito, Noritaka, Yamaguchi, Satoshi, Takazawa, Ryoji, Tsujihata, Masao, Matsuda, Tadashi, Akakura, Koichiro, Hata, Akira, Ichikawa, Tomohiko

“…Objectives To assess epidemiological and chronological trends of upper urinary tract stones in Japan in 2015. Methods Patients with a first episode of upper…”
Get full text

External validation of the Candiolo nomogram for high-risk prostate cancer patients treated with carbon ion radiotherapy plus androgen deprivation therapy: a retrospective cohort study by Utsumi, Takanobu, Suzuki, Hiroyoshi, Ishikawa, Hitoshi, Hiroshima, Yuichi, Wakatsuki, Masaru, Harada, Masaoki, Ichikawa, Tomohiko, Akakura, Koichiro, Tsuji, Hiroshi

“…Abstract The aim of this study was to reclassify high-risk prostate cancer patients treated with carbon-ion radiotherapy and androgen deprivation therapy using…”
Get full text

Comparison of the medical costs between active surveillance and other treatments for early prostate cancer in Japan using data from the PRIAS‐JAPAN study by Kato, Takuma, Yokomizo, Akira, Matsumoto, Ryuji, Tohi, Yoichiro, Miyakawa, Jimpei, Mitsuzuka, Koji, Sasaki, Hiroshi, Inokuchi, Junichi, Matsumura, Masafumi, Sakamoto, Shinichi, Kinoshita, Hidefumi, Fukuhara, Hiroshi, Kamiya, Naoto, Kimura, Ryu, Nitta, Masahiro, Okuno, Hiroshi, Akakura, Koichiro, Kakehi, Yoshiyuki, Sugimoto, Mikio

“…Objectives To compare the medical costs of active surveillance with those of robot‐assisted laparoscopic prostatectomy, brachytherapy, intensity‐modulated…”
Get full text

Intermittent hormone therapy by Akakura, Koichiro

Get more information

Updated long‐term outcomes after carbon‐ion radiotherapy for primary renal cell carcinoma by Kasuya, Goro, Tsuji, Hiroshi, Nomiya, Takuma, Makishima, Hirokazu, Haruyama, Yasuo, Kobashi, Gen, Ebner, Daniel K., Hayashi, Kazuhiko, Omatsu, Tokuhiko, Kishimoto, Riwa, Yasuda, Shigeo, Igarashi, Tatsuo, Oya, Mototsugu, Akakura, Koichiro, Suzuki, Hiroyoshi, Ichikawa, Tomohiko, Shimazaki, Jun, Kamada, Tadashi

“…Long‐term oncological outcomes for primary renal cell carcinoma (RCC) treated with carbon‐ion radiotherapy (CIRT) are poorly understood. Patients with primary…”
Get full text

Carbon Ion Radiotherapy in Advanced Hypofractionated Regimens for Prostate Cancer: From 20 to 16 Fractions by Okada, Tohru, MD, PhD, Tsuji, Hiroshi, MD, PhD, Kamada, Tadashi, MD, PhD, Akakura, Koichiro, MD, PhD, Suzuki, Hiroyoshi, MD, PhD, Shimazaki, Jun, MD, PhD, Tsujii, Hirohiko, MD, PhD

“…Purpose To assess the effects of differences in dose fractionation on late radiation toxicity and biochemical control in patients with prostate cancer treated…”
Get full text

Hormonal therapy for advanced prostate cancer: current status and issues by Akakura, Koichiro

“…For advanced prostate cancer, hormonal therapy has been utilized as the first choice of treatment. In general, initial hormonal therapy consists of androgen…”
Get more information

Cancer‐specific mortality of high‐risk prostate cancer after carbon‐ion radiotherapy plus long‐term androgen deprivation therapy by Kasuya, Goro, Ishikawa, Hitoshi, Tsuji, Hiroshi, Haruyama, Yasuo, Kobashi, Gen, Ebner, Daniel K., Akakura, Koichiro, Suzuki, Hiroyoshi, Ichikawa, Tomohiko, Shimazaki, Jun, Makishima, Hirokazu, Nomiya, Takuma, Kamada, Tadashi, Tsujii, Hirohiko

“…The treatment outcomes of patients with high‐risk localized prostate cancer (PC) after carbon‐ion radiotherapy (CIRT) combined with long‐term androgen…”
Get full text

Diagnostic Impacts of Clinical Laboratory Based p2PSA Indexes on any Grade, Gleason Grade Group 2 or Greater, or 3 or Greater Prostate Cancer and Prostate Specific Antigen below 10 ng/ml by Ito, Kazuto, Yokomizo, Akira, Tokunaga, Shoji, Arai, Gaku, Sugimoto, Mikio, Akakura, Koichiro, Hasumi, Hisashi, Sakai, Hideki, Ouraji, Akiko, Oki, Ryo, Kashiwagi, Eiji, Kobori, Yoshitomo, Hirama, Hiromi, Kitoh, Hiroki, Uemura, Hiroji, Hakariya, Tomoaki, Suzuki, Kazuhiro

“…The PROPHET (Prostate Cancer: Prostate Health Index Trial) is a prospective study to clarify the diagnostic impact of laboratory based and prostate volume…”
Get full text

Editorial Comment to Safety and tolerability of intermittent androgen deprivation therapy: A literature review by Akakura, Koichiro

Get full text

Tumor Location and a Tumor Volume over 2.8 cc Predict the Prognosis for Japanese Localized Prostate Cancer by Baba, Haruki, Sakamoto, Shinichi, Zhao, Xue, Yamada, Yasutaka, Rii, Junryo, Fujimoto, Ayumi, Kanesaka, Manato, Takeuchi, Nobuyoshi, Sazuka, Tomokazu, Imamura, Yusuke, Akakura, Koichiro, Ichikawa, Tomohiko

“…(1) Objective: Our study investigated the prognostic value of tumor volume and location in prostate cancer patients who received radical prostatectomy (RP)…”
Get full text